Greg Scutt

Keyphrases

1. Older People 100%
2. Adverse Drug Reaction 79%
3. Brighton 60%
4. Comorbidity 58%
5. Pharmacokinetics 48%
6. Antioxidant 48%
7. Aging 47%
8. Nuclear Factor Erythroid 2-like 2 39%
9. Old Age 36%
10. Genotype 35%
11. Age-related Changes 35%
12. Polymorphism 31%
13. Single nucleotide Polymorphism 31%
14. Pharmacy Students 30%
15. Older Adults 28%
16. Age-related 27%
17. Pharmacokinetic Parameters 27%
18. Blood Samples 27%
19. Implicit Memory 24%
20. Executive Function 24%
21. Clinical Decision-making 24%
22. Nuclear Factor Erythroid 2-related Factor 2 (Nrf2) 24%
23. Vaccination Clinic 24%
24. MRNA Nanoparticles 24%
25. Translational Studies 24%
26. UK Hospitals 24%
27. Lipid-based Formulation 24%
28. Pfizer-BioNTech BNT162b2 24%
29. Potentially Inappropriate Medication 24%
30. Rs6295 24%
31. Citalopram 24%
32. Anti-drug 24%
33. Warfarin Sensitivity 24%
34. 5-HT1A 24%
35. Defense Genes 24%
36. Avoided Deaths 24%
37. Benefits of Vaccination 24%
38. Vaccination against SARS-CoV-2 24%
39. Drug-metabolizing Genes 24%
40. Direct Oral Anticoagulants 24%
41. Brain-derived Neutrophic Factor 24%
42. Rs6265 24%
43. Val66Met Polymorphism 24%
44. G196A 24%
45. Periodic Table 24%
46. Sodium-calcium Exchanger 24%
47. Slow Afterhyperpolarization 24%
48. Vitamin K Antagonists 24%
49. Patient Care 24%
50. Nitric Oxide 24%